1. Home
  2. TRVI vs SB Comparison

TRVI vs SB Comparison

Compare TRVI & SB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • SB
  • Stock Information
  • Founded
  • TRVI 2011
  • SB 2007
  • Country
  • TRVI United States
  • SB Monaco
  • Employees
  • TRVI N/A
  • SB N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • SB Marine Transportation
  • Sector
  • TRVI Health Care
  • SB Consumer Discretionary
  • Exchange
  • TRVI Nasdaq
  • SB Nasdaq
  • Market Cap
  • TRVI 341.4M
  • SB 368.4M
  • IPO Year
  • TRVI 2019
  • SB 2008
  • Fundamental
  • Price
  • TRVI $3.76
  • SB $3.44
  • Analyst Decision
  • TRVI Strong Buy
  • SB Strong Buy
  • Analyst Count
  • TRVI 8
  • SB 1
  • Target Price
  • TRVI $9.31
  • SB $6.00
  • AVG Volume (30 Days)
  • TRVI 659.4K
  • SB 651.0K
  • Earning Date
  • TRVI 11-06-2024
  • SB 02-10-2025
  • Dividend Yield
  • TRVI N/A
  • SB 4.39%
  • EPS Growth
  • TRVI N/A
  • SB 35.10
  • EPS
  • TRVI N/A
  • SB 0.90
  • Revenue
  • TRVI N/A
  • SB $318,430,000.00
  • Revenue This Year
  • TRVI N/A
  • SB $6.67
  • Revenue Next Year
  • TRVI N/A
  • SB N/A
  • P/E Ratio
  • TRVI N/A
  • SB $3.81
  • Revenue Growth
  • TRVI N/A
  • SB 10.27
  • 52 Week Low
  • TRVI $1.27
  • SB $3.37
  • 52 Week High
  • TRVI $4.68
  • SB $6.33
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 48.03
  • SB 38.75
  • Support Level
  • TRVI $3.63
  • SB $3.37
  • Resistance Level
  • TRVI $4.06
  • SB $3.59
  • Average True Range (ATR)
  • TRVI 0.30
  • SB 0.12
  • MACD
  • TRVI -0.09
  • SB 0.01
  • Stochastic Oscillator
  • TRVI 12.21
  • SB 17.57

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About SB Safe Bulkers Inc ($0.001 par value)

Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services.

Share on Social Networks: